Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Raw Materials (2016 - 2021)

Historic Raw Materials for Medifast (MED) over the last 9 years, with Q3 2021 value amounting to $13.8 million.

  • Medifast's Raw Materials rose 100.72% to $13.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $13.8 million, marking a year-over-year increase of 100.72%. This contributed to the annual value of $13.4 million for FY2020, which is 2341.91% up from last year.
  • Per Medifast's latest filing, its Raw Materials stood at $13.8 million for Q3 2021, which was up 100.72% from $9.5 million recorded in Q2 2021.
  • In the past 5 years, Medifast's Raw Materials registered a high of $13.8 million during Q3 2021, and its lowest value of $4.3 million during Q3 2017.
  • Moreover, its 5-year median value for Raw Materials was $10.5 million (2019), whereas its average is $9.6 million.
  • In the last 5 years, Medifast's Raw Materials plummeted by 2771.4% in 2017 and then surged by 21215.9% in 2018.
  • Quarter analysis of 5 years shows Medifast's Raw Materials stood at $4.3 million in 2017, then surged by 156.58% to $11.2 million in 2018, then fell by 2.47% to $10.9 million in 2019, then increased by 23.42% to $13.4 million in 2020, then grew by 3.07% to $13.8 million in 2021.
  • Its last three reported values are $13.8 million in Q3 2021, $9.5 million for Q2 2021, and $11.2 million during Q1 2021.